Schedule 13G ownership disclosure

DelMar Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 247078306

Event date: 2019-08-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
675,000
Percent of class
8.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-047053
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Aug 23, 2019
Reporting period
Aug 14, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub